NEW YORK (
CHANGE IN RATINGS
Automatic Data Processing
downgraded at Jefferies to Underperform from Hold, Jefferies said. $55 price target. Employment markets remain challenged.
upgraded at Citigroup to Buy from Neutral, Citigroup said. $118 price target. Nitrogen has the best near term outlook. Company also added to Top Picks Live!
downgraded at Baird from Outperform to Neutral, Robert Baird said. $84 price target. Valuation call, as the stock is up 75% since last August.
upgraded at JP Morgan to Overweight, JP Morgan said. Recent asset sales improves the company's earnings outlook.
coverage initiated with a sell rating at TheStreet Ratings.
Coeur D'Alene Mines
upgraded to buy at TheStreet Ratings.
Cohen & Steers
downgraded at Goldman to Sell. Poor performance figures could drive fund outflows.
downgraded at UBS to Sell from Neutral, UBS said. $31 price target. Slide in power and retail outlook.
upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Potential money market fund reform has been delayed by the SEC. $20 price target.
downgraded at Sterne Agee to Underperform, Sterne Agee said. $20 price target. Estimates also cut, as the company is losing market share.
upgraded at JP Morgan to Overweight, JP Morgan said. Estimates also boosted, given better clarity on the company's pending rate cases.
upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $60 price target. Stock is attractive, following a 14% pullback.
upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $36 price target.
upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $62 price target. Stock trades at a low valuation and sales trends are improving.
downgraded at Jefferies to Underperform from Hold, Jefferies said. $31 price target. The interest rate environment will be a lingering headwind.
downgraded at Wells to Underperform, Wells Fargo said. Company cut its production forecast.
upgraded at Williams from Hold to Buy, Williams Financial said. $17 price target. Company is improving existing markets and keeping a tight lid on costs.
downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $34 price target.
downgraded at Citigroup to Neutral from Buy, Citigroup said. $47 price target. Potash market remains weak despite a run up in grain prices.
upgraded at Williams from Hold to Buy, Williams Financial said. $46 price target. Company can prosper, even with a slower macro environment.
downgraded at UBS to Neutral from Buy, UBS said. $7 price target. Fairly valued after recent move.
STOCK COMMENTS / EPS CHANGES
target raised at Hudson Square to $900, according to Hudson Square. Company should see multiple expansion. Buy rating.
numbers raised at Citigroup. Shares of AB now seen reaching $17, Citigroup said. Estimates also increased as company offers significant operating leverage as volumes heal. Buy rating.
target lowered at Jefferies. Shares of ALR now seen reaching $26, Jefferies said. Triage FDA issues remain unsettled. Buy rating.
numbers raised at UBS. Shares of BEN now seen reaching $120, UBS said. Estimates also increased as monthly flows accelerate in August. Neutral rating.
Franklin Resources numbers increased at BMO. BEN estimates were raised through 2013, BMO Capital said. Company is attracting more assets. Market Perform rating and new $127 price target.
numbers boosted at Sterne Agee. Shares of FHN now seen reaching $11, according to Sterne Agee. Estimates also raised, as the company is improving efficiency. Neutral rating.
estimates, target lowered at Credit Suisse. PCAR estimates were cut through 2014, Credit Suisse said. Company continues to see lower U.S. demand. Neutral rating and new $43 price target.
numbers raised at Oppenheimer. Shares of V now seen reaching $150, Oppenheimer said. Estimates also raised on accelerating August trends. Outperform rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
This article was written by a staff member of TheStreet.